Literature DB >> 28143936

EBI3 regulates the NK cell response to mouse cytomegalovirus infection.

Helle Jensen1, Shih-Yu Chen2, Lasse Folkersen3, Garry P Nolan2, Lewis L Lanier4,5.   

Abstract

Natural killer (NK) cells are key mediators in the control of cytomegalovirus infection. Here, we show that Epstein-Barr virus-induced 3 (EBI3) is expressed by human NK cells after NKG2D or IL-12 plus IL-18 stimulation and by mouse NK cells during mouse cytomegalovirus (MCMV) infection. The induction of EBI3 protein expression in mouse NK cells is a late activation event. Thus, early activation events of NK cells, such as IFNγ production and CD69 expression, were not affected in EBI3-deficient (Ebi3-/- ) C57BL/6 (B6) mice during MCMV infection. Furthermore, comparable levels of early viral replication in spleen and liver were observed in MCMV-infected Ebi3-/- and wild-type (WT) B6 mice. Interestingly, the viral load in salivary glands and oral lavage was strongly decreased in the MCMV-infected Ebi3-/- B6 mice, suggesting that EBI3 plays a role in the establishment of MCMV latency. We detected a decrease in the sustained IL-10 production by NK cells and lower serum levels of IL-10 in the MCMV-infected Ebi3-/- B6 mice. Furthermore, we observed an increase in dendritic cell maturation markers and an increase in activated CD8+ T cells. Thus, EBI3 dampens the immune response against MCMV infection, resulting in prolonged viral persistence.

Entities:  

Keywords:  EBI3; cytomegalovirus; natural killer cell

Mesh:

Substances:

Year:  2017        PMID: 28143936      PMCID: PMC5321027          DOI: 10.1073/pnas.1700231114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Role of chemokines in the biology of natural killer cells.

Authors:  Michael J Robertson
Journal:  J Leukoc Biol       Date:  2002-02       Impact factor: 4.962

Review 2.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

3.  EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation.

Authors:  Stefan Wirtz; Christoph Becker; Massimo C Fantini; Edward E Nieuwenhuis; Ingrid Tubbe; Peter R Galle; Hans-Jörg Schild; Mark Birkenbach; Richard S Blumberg; Markus F Neurath
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

4.  Cutting edge: stage-specific requirement of IL-18 for antiviral NK cell expansion.

Authors:  Sharline Madera; Joseph C Sun
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

5.  Proliferation conditions promote intrinsic changes in NK cells for an IL-10 response.

Authors:  Margarite L Tarrio; Seung-Hwan Lee; Maria F Fragoso; Hong-Wei Sun; Yuka Kanno; John J O'Shea; Christine A Biron
Journal:  J Immunol       Date:  2014-06-06       Impact factor: 5.422

6.  Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10.

Authors:  Jason S Stumhofer; Jonathan S Silver; Arian Laurence; Paige M Porrett; Tajie H Harris; Laurence A Turka; Matthias Ernst; Christiaan J M Saris; John J O'Shea; Christopher A Hunter
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

7.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

8.  A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes.

Authors:  O Devergne; M Hummel; H Koeppen; M M Le Beau; E C Nathanson; E Kieff; M Birkenbach
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Interleukin-35 induces regulatory B cells that suppress autoimmune disease.

Authors:  Ren-Xi Wang; Cheng-Rong Yu; Ivy M Dambuza; Rashid M Mahdi; Monika B Dolinska; Yuri V Sergeev; Paul T Wingfield; Sung-Hye Kim; Charles E Egwuagu
Journal:  Nat Med       Date:  2014-04-17       Impact factor: 53.440

10.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Authors:  Daehwan Kim; Geo Pertea; Cole Trapnell; Harold Pimentel; Ryan Kelley; Steven L Salzberg
Journal:  Genome Biol       Date:  2013-04-25       Impact factor: 13.583

View more
  6 in total

1.  KLF12 Regulates Mouse NK Cell Proliferation.

Authors:  Viola C Lam; Lasse Folkersen; Oscar A Aguilar; Lewis L Lanier
Journal:  J Immunol       Date:  2019-07-12       Impact factor: 5.422

2.  STING-induced regulatory B cells compromise NK function in cancer immunity.

Authors:  Sirui Li; Bhalchandra Mirlekar; Brandon M Johnson; W June Brickey; John A Wrobel; Na Yang; Dingka Song; Sarah Entwistle; Xianming Tan; Meng Deng; Ya Cui; Wei Li; Benjamin G Vincent; Michael Gale; Yuliya Pylayeva-Gupta; Jenny P-Y Ting
Journal:  Nature       Date:  2022-10-05       Impact factor: 69.504

Review 3.  Spatial and temporal coordination of antiviral responses by group 1 ILCs.

Authors:  Nicholas M Adams; Joseph C Sun
Journal:  Immunol Rev       Date:  2018-11       Impact factor: 12.988

4.  NK cell receptor and ligand composition influences the clearance of SARS-CoV-2.

Authors:  Wan-Chen Hsieh; En-Yu Lai; Yu-Ting Liu; Yi-Fu Wang; Yi-Shiuan Tzeng; Lu Cui; Yun-Ju Lai; Hsiang-Chi Huang; Jia-Hsin Huang; Hung-Chih Ni; Dong-Yan Tsai; Jian-Jong Liang; Chun-Che Liao; Ya-Ting Lu; Laurence Jiang; Ming-Tsan Liu; Jann-Tay Wang; Sui-Yuan Chang; Chung-Yu Chen; Hsing-Chen Tsai; Yao-Ming Chang; Gerlinde Wernig; Chia-Wei Li; Kuo-I Lin; Yi-Ling Lin; Huai-Kuang Tsai; Yen-Tsung Huang; Shih-Yu Chen
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

5.  Tissue-specific control of latent CMV reactivation by regulatory T cells.

Authors:  Maha Almanan; Jana Raynor; Allyson Sholl; Mei Wang; Claire Chougnet; Rhonda D Cardin; David A Hildeman
Journal:  PLoS Pathog       Date:  2017-08-10       Impact factor: 6.823

Review 6.  The Effect of Unconventional Cytokine Combinations on NK-Cell Responses to Viral Infection.

Authors:  David E Ochayon; Stephen N Waggoner
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.